
|Articles|June 8, 2022
Daily Medication Pearl: Duloxetine Hydrochloride (Cymbalta)
Author(s)Saro Arakelians, PharmD
Cymbalta is a serotonin and norepinephrine reuptake inhibitor indicated for major depressive disorder and anxiety, diabetic peripheral neuropathy, fibromyalgia, and chronic pain related to the muscles and bones.
Advertisement
Medication Pearl of the Day: Duloxetine Hydrochloride (Cymbalta)
Indication: Cymbalta is a serotonin and norepinephrine reuptake inhibitor indicated for major depressive disorder and anxiety, diabetic peripheral neuropathy, fibromyalgia, and chronic pain related to the muscles and bones.
Insight:
- Dosing: May vary based on the indication from 40 to 120 mg per day.
- Dosage forms: 20 mg, 30 mg, and 60 mg capsules.
- Adverse events: Most common adverse reactions (≥5% and at least twice the incidence of placebo patients): nausea, dry mouth, somnolence, fatigue, constipation, decreased appetite, and hyperhidrosis.
- Mechanism of action: Although the exact mechanisms of the antidepressant, central pain inhibitory, and anxiolytic actions of duloxetine in humans are unknown, these actions are believed to be related to its potentiation of serotonergic and noradrenergic activity in the central nervous system.
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
3
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
4
A Defining Moment for Health System Pharmacy: Advancing Competency, Policy, and Patient Need in 2026
5

























